Efficacy of Respiratory Physiotherapy on Severe ICU-admitted COVID-19 Patients.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

244 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-01

Study Completion Date

2021-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

COVID-19 is an infectious disease caused by SARS-CoV2 virus. COVID-19 patients can develop a severe disease that can lead to hypoxic respiratory failure and acute respiratory distress syndrome (ARDS). Severe patients can require access to intensive care unit (ICU). Early rehabilitation is known to be effective in critically ill patients and in ARDS.

Early rehabilitation is known to be effective in critically ill subjects. The role of physiotherapy in severe COVID-19 patients is still unclear and few guidelines have been proposed so far. Aim of this study is to assess efficacy of early rehabilitation for severe ICU-admitted COVID-19 patients as compared to a group that did not received physiotherapy treatment in ICU.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Respiratory Physiotherapy in Severe COVID-19 Patients

NCT04459819

COVID-19

COMPLETED

Implementation of Physiotherapy on COVID-19 Patients in ICU

NCT04347070

Sars-CoV2 COVID-19

UNKNOWN

Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care

NCT04396197

COVID-19 Critical Illness Ards +1 more

COMPLETED

Rehabilitation Practices in Critically Ill Patients Receiving Invasive Mechanical Ventilation in the Intensive Care Unit.

NCT07093125

Mechanical Ventilation Pulmonary Rehabilitation Intensive Care Units (ICUs) +5 more

NOT_YET_RECRUITING

Global Physiotherapy in ICU Patients With High Risk Extubation Failure

NCT05423301

Acute Respiratory Failure

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

COVID-19 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged in China in December 2019 and in Italy in February 2020. A large proportion of infected people have mild clinical manifestations, whereas \>10% develop a severe disease, which could evolve into acute hypoxemic respiratory failure (AHRF) and acute respiratory distress syndrome (ARDS) requiring intensive care unit (ICU) admission. A high proportion of ICU patients need invasive mechanical ventilation (IMV) and about 50% of the ICU-admitted patients die. The median age of ICU COVID-19 patients was \<65 years and the mortality in patients aged \<63 years ranges from 15 to 20%.

Early rehabilitation is safe and effective in critically ill patients and, in patients with ARDS, it helps to reduce the functional impairment due to the prolonged stay in ICU. Preliminary data suggest the implementation of early and active mobilization programs, as well as airway clearance, for patients with severe forms of COVID-19. To date, the role of respiratory physiotherapy in severe COVID-19 patients is still unclear.

Aim of this study is to assess efficacy of early rehabilitation for severe ICU-admitted COVID-19 patients as compared to a group that did not recevied physiotherapy treatment in ICU. Physiotherapy efficacy is evaluated in terms of ventilator free days (VFD) during the first 30 days after neuromuscular blockade stop.

Moreover, duration of ICU stay and patient functional status at ICU discharge will be evaluated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Acute Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

COVID-19 ICU-admitted patients that did not received physiotherapy interventions during ICU stay.

No interventions assigned to this group

Physiotherapy

COVID-19 ICU-admitted patients that received physiotherapy interventions during ICU stay.

Early physiotherapy

Intervention Type PROCEDURE

Respiratory physiotherapy included:

1. early and functional mobilization: passive and active mobilization, muscle strengthening, improving independence in activities of daily living (ADL), sitting out of bed, standing, walking;
2. patient positioning to achieve better ventilation/perfusion ratio and gas exchange;
3. airway clearance;
4. aerosol administration;
5. invasive mechanical ventilation weaning;
6. use of non-invasive mechanical ventilation (NIMV) and continuous positive airway pressure (CPAP);
7. tracheostomy management and weaning;
8. swallowing assessment;
9. management of oxygen delivery;
10. lung expansion;
11. patient assessment and functional scale administration.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early physiotherapy

Respiratory physiotherapy included:

1. early and functional mobilization: passive and active mobilization, muscle strengthening, improving independence in activities of daily living (ADL), sitting out of bed, standing, walking;
2. patient positioning to achieve better ventilation/perfusion ratio and gas exchange;
3. airway clearance;
4. aerosol administration;
5. invasive mechanical ventilation weaning;
6. use of non-invasive mechanical ventilation (NIMV) and continuous positive airway pressure (CPAP);
7. tracheostomy management and weaning;
8. swallowing assessment;
9. management of oxygen delivery;
10. lung expansion;
11. patient assessment and functional scale administration.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

respiratory physiotherapy early rehabilitation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having laboratory confirmed COVID-19 pneumonia
* Developed hypoxemic acute respiratory failure (hARF) requiring access to ICU
* Treated by physiotherapists during the ICU stay
* Stopped the neuromuscular blokade treatment